Patients with certain types of blood cancers that express the CD30 protein, such as classical Hodgkin’s lymphoma, systemic anaplastic large cell lymphoma, and cutaneous T-cell lymphoma, often experience relapses or resistance to treatment. This evidence concerns the gene TNFRSF8 and Hodgkins lymphoma.